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Research
Ambient air pollution, especially particulate
matter (PM), has increasingly been recognized
as a threat to cardiovascular health (Kaiser
2005; Nel 2005). As noted in a recent compre-
hensive review of the mounting volume of epi-
demiology literature (Pope and Dockery
2006), multicity air pollution studies using
time-series or case–crossover analyses have
reported fairly consistent associations between
elevated PM concentrations over short periods
of one or several days and increased cardio-
vascular mortality and morbidity (e.g., hospi-
talizations, emergency visits). Compelling data
also link PM directly to specific cardiac
events, including life-threatening arrhythmia
(Dockery et al. 2005; Peters et al. 2000) and
myocardial infarction (Zanobetti and Schwartz
2005). Since the 1990s, convincing evidence
from large cohort studies has consistently
demonstrated that long-term exposures to par-
ticulate air pollutants are associated with
increased mortality. Both the Harvard Six-
Cities Study (Dockery et al. 1993) and the
American Cancer Society cohort study (Pope
et al. 1995) reported that people residing in
more polluted areas with high PM2.5 (PM with
aerodynamic diameter < 2.5 µm), compared
with those in less polluted areas, were more
likely to die, and stronger associations were
found with cardiopulmonary deaths. Yearly
average of PM10 (aerodynamic diameter
< 10 µm) was also associated with increased
risks for hospitalization for congestive heart
failure or recurrent heart attack among patients
with previous myocardial infarction (Zanobetti
and Schwartz 2007).
More recently, environmental health scien-
tists have begun to elucidate the pathophysio-
logic mechanisms underlying the observed
adverse short-term and long-term cardiac
effects of ambient air pollution, and several
interrelated mechanistic pathways have been
proposed. Because of the pivotal role of vascular
inﬂammation in pathogenesis and progression
of atherosclerosis and coronary heart diseases,
systemic inflammatory response to inhaled
ambient particles has emerged as an important
mediator of PM-associated acute cardiac effects
(Pope 2000; Utell et al. 2002). Although much
progress has been made in understanding the
mechanisms of acute cardiac effects, human
data are scant and conﬂicting with respect to the
pathophysiologic mediators of cardiovascular
disease (CVD) associated with long-term PM
exposure. For instance, short-term elevation of
ambient PM is associated with increased levels
of inﬂammatory markers such as white blood
cell (WBC) count (Liao et al. 2005; Schwartz
2001) and C-reactive protein (Peters et al.
2001; Pope et al. 2004). However, the link
between inflammation and long-term PM
exposure in human is still lacking.
The increasing prevalence and large num-
ber of U.S. adults (with an age-adjusted preva-
lence of 23–24%) with metabolic syndrome
(MS) has imposed a major public health con-
cern and presented a great challenge to health
care (Ford et al. 2002; Grundy et al. 2004). A
known precursor of CVD and type 2 diabetes
(Wilson et al. 2005), the MS comprises a clus-
ter of abnormalities that occur as a result of
perturbations in multiple metabolic pathways,
leading to central adiposity, insulin resistance,
hyperglycemia, atherogenic dyslipidemia, and
hypertension. Recent epidemiologic data have
suggested that the presence of certain compo-
nent abnormalities of MS, such as obesity
(Chen et al. 2007; Dubowsky et al. 2006;
Schwartz et al. 2005), hypertension (Holguin
et al. 2003; Liao et al. 2005; Park et al. 2005),
and diabetes mellitus (O’Neill et al. 2005;
Park et al. 2005), may impart greater suscepti-
bility to PM-associated cardiac effects. A lack
of understanding of who is most at risk or sus-
ceptible is one of the most important gaps in
our current knowledge regarding PM-related
health effects (Pope and Dockery 2006).
However, no prior studies have examined
MS-dependent inflammatory responses to
long-term PM exposure.
The following secondary data analyses
were carried out to address these significant
data gaps. We hypothesized that long-term
PM exposure is associated with increased sys-
temic inflammation, and that people with
MS have a higher degree of inflammatory
responses to PM.
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BACKGROUND: Human data linking inﬂammation with long-term particulate matter (PM) exposure
are still lacking. Emerging evidence suggests that people with metabolic syndrome (MS) may be a
more susceptible population.
OBJECTIVES: Our goal was to examine potential inﬂammatory responses associated with long-term
PM exposure and MS-dependent susceptibility.
METHODS: We conducted secondary analyses of white blood cell (WBC) count and MS data from
The Third National Health and Nutrition Examination Survey and PM10 (PM with aerodynamic
diameter < 10 µm) data from the U.S. Environmental Protection Agency Aerometric Information
Retrieval System. Estimated 1-year PM10 exposures were aggregated at the centroid of each residen-
tial census-block group, using distance-weighted averages from all monitors in the residing and
adjoining counties. We restricted our analyses to adults (20–89 years of age) with normal WBC
(4,000–11,000 × 106/L), no existing cardiovascular disease, complete PM10 and MS data, and liv-
ing in current residences > 1 year (n = 2,978; age 48.5 ± 17.8 years). Mixed-effects models were
constructed to account for autocorrelation and potential confounders.
RESULTS: After adjustment for demographics, socioeconomic factors, lifestyles, residential charac-
teristics, and MS, we observed a statistically signiﬁcant association between WBC count and esti-
mated local PM10 levels (p = 0.035). Participants from the least polluted areas (1-year PM10 < 1st
quartile cutoff: 27.8 µg/m3) had lower WBC counts than the others (difference = 145 × 106/L;
95% conﬁdence interval, 10–281). We also noted a graded association between PM10 and WBC
across subpopulations with increasing MS components, with 91 × 106/L difference in WBC for those
with no MS versus 214, 338, and 461 × 106/L for those with 3, 4, and 5 metabolic abnormalities
(trend-test p = 0.15).
CONCLUSIONS: Our study revealed a positive association between long-term PM exposure and hema-
tological markers of inﬂammation and supported the hypothesized MS-dependent susceptibility.
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Health data source. The extant health data
came from the Third National Health and
Nutrition Examination Survey (NHANES
III) conducted by the National Center for
Health Statistics of the Centers for Disease
Control and Prevention between 1988 and
1994. Details about this survey and related
methods have been published (National
Center for Health Statistics 1995). In brief,
the NHANES III followed a multistage strati-
ﬁed random sampling of the U.S. population,
with oversampling of minorities (African
Americans, Mexican Americans) and the
elderly (≥ 60 years of age). The survey con-
sisted of an extensive household interview fol-
lowed by a series of laboratory and other
physical tests in a mobile examination center
(MEC). Only those who completed the
household interview were invited for the MEC
examination. NHANES III was conducted in
two phases, 1989–1991 and 1991–1994, each
sampling approximately 20,000 subjects from
44 and 45 communities, respectively, that
comprised a national probability sample. The
current study was restricted to health data col-
lected in 1989–1991, because we accessed
only geocodes of phase 1 participants.
Study population of current analyses. To
parallel previous analyses on MS in U.S. adults
(Ford et al. 2002; Ninomiya et al. 2004), our
study focused on NHANES III participants
20–89 years of age, although the entire survey
covered all civilian, noninstitutionalized per-
sons ≥ 2 months of age. Other eligibility crite-
ria included a) no existing or prior histories of
heart attack or stroke as told by physicians;
b) living in current residence > 1 year; c) WBC
count between 4,000 and 11,000 cells × 106;
and d) having complete laboratory and physi-
cal data to define the presence or absence of
MS. We excluded all subjects with WBC
> 11,000 or < 4,000 cells × 106/L because
they likely reflected either acute pathologic
processes or underlying diseases.
Outcome data. For the current analysis,
we used the between-individual difference in
WBC count as a marker of systemic inflam-
mation. WBC count was included as part of
the complete blood count performed using
the Coulter Counter Model S-PLUS JR
automated hematology analyzer (Coulter
Electronics, Hialeah, FL). WBC count is an
inflammatory marker and is considered a
potentially useful predictor of prevalent or
incident CVD, according to the joint scien-
tific statement by the Centers for Disease
Control and Prevention and the American
Heart Association (Pearson et al. 2003).
Although C-reactive protein is also a valid
inflammatory biomarker for CVD, the
NHANES laboratory tests did not use a high-
sensitivity assay for C-reactive protein until
1999–2000.
Ambient air pollution data. During the
period of NHANES III, the only environmen-
tal monitoring data of ambient particles avail-
able nationwide were for PM10. We obtained
the PM10 data from the U.S. Environmental
Protection Agency (EPA) Aerometric
Information Retrieval System (AIRS), which
has evolved into the current U.S. EPA Air
Quality System and contains information on
all routine air pollution monitoring (U.S. EPA
2007). The approach to estimating daily expo-
sure levels of major criteria air pollutants
(PM10, ozone, nitrogen dioxide, sulfur dioxide)
has been published elsewhere (Schwartz 2001).
In brief, air pollution exposure was assigned to
subjects on the basis of geocoding. The resi-
dential information needed for geocoding was
obtained through an agreement with the
National Center for Health Statistics. Each
participant in NHANES III was assigned the
latitude and longitude of the population cen-
troid of the census block group in which they
lived. Block groups are collections of adjoining
blocks with populations of 500–1,000 persons.
The boundaries of block groups are chosen to
maximize similarity within group on socio-
economic factors. The latitude and longitude
of each monitor was also retrieved from AIRS
(U.S. EPA 2007). Individuals were assigned
exposure values equal to the weighted average
of all monitors in their county of residence and
adjoining counties, with weights proportional
to the inverse of the square of the distance
between their residence and the monitor. The
use of all monitors in the county of residence
and adjoining counties allowed geographic
variability in exposure within area to be
reﬂected in the exposure measures.
Definition of MS. The profiling of MS
characteristics required data from the
NHANES III adult questionnaire, MEC
examination, and laboratory tests. We applied
condition-speciﬁc cut points for MS, using the
criteria given by the National Cholesterol
Education Program (NCEP) for Detection,
Evaluation, and Treatment of High Blood
Cholesterol in Adult Treatment Panel III
(NCEP 2001), with similar minor modiﬁca-
tions as used by others (Ford et al. 2002;
Ninomiya et al. 2004). The five component
conditions are insulin resistance (IR), high
blood pressure, hypertriglyceridemia, low high-
density lipoprotein cholesterol (HDL-C), and
abdominal obesity. IR was deﬁned as fasting
glucose ≥ 110 mg/dL; for this analysis, IR
could also be deﬁned by a self-report of current
use of insulin or oral hypoglycemics. High
blood pressure was defined as systolic blood
pressure ≥ 130 mmHg or diastolic blood pres-
sure ≥ 85 mmHg. For this analysis, high blood
pressure could also be deﬁned by a self-report
of current use of antihypertensive medication.
Hypertriglyceridemia was identiﬁed based on
triglycerides ≥ 150 mg/dL. Low HDL-C was
identiﬁed by HDL-C < 40 mg/dL in men or
< 50 mg/dL in women. Abdominal obesity was
deﬁned as a waist circumference > 102 cm in
men or > 88 cm in women.
We measured fasting plasma glucose using
a modified hexokinase enzymatic method
(Cobas Mira assay; Roche, Basel, Switzerland).
The interassay coefficient of variation was
< 4% during the entire 6 years of survey. We
evaluated history of diabetes based on a posi-
tive response to either of the questions “Are
you now taking insulin?” or “Are you now
taking diabetes pills to lower your blood
sugar? These are sometimes called oral agents
or oral hypoglycemic agents.” Blood pressure
was measured by a board-eligible physician.
Treatment for hypertension was identiﬁed by
positive responses to all three of the following
questions: “Have you ever been told by a doc-
tor or other health professional that you had
hypertension, also called high blood pres-
sure?”; “Because of your high blood pressure/
hypertension, have you ever been told by a
doctor or other health professional to take pre-
scribed medicine?”; and “Are you now taking
prescribed medicine?” Triglycerides and
HDL-C were measured using a Hitachi 704
Analyzer (Boehringer Mannheim Diagnostics,
Indianapolis, IN). Waist circumference was
measured, by a trained examiner, at the mid-
point between the bottom of the rib cage and
above the top of the iliac crest from participants
at minimal respiration to the nearest 0.1 cm.
Relevant covariate data. Information on
relevant covariates was collected through a
structured interview. We determined the fol-
lowing covariates as important confounders:
age, sex, race/ethnicity (non-Hispanic white,
non-Hispanic black, Hispanic, and other),
socioeconomic status [education (< 8, 8–12,
> 12 years), annual family income (< $20,000,
$20,000–35,000, $35,000–50,000, > $50,000),
employment status], family size, poverty–
income ratio (in quartiles), and degree of
urbanization of the residential neighborhoods.
We used these latter two variables to measure
some contextual characteristics other than the
ambient air pollution exposure within the resi-
dential environment. The poverty–income
ratio, as derived by comparing the self-
reported family income to the U.S. Census–
based poverty threshold value for each calendar
year adjusted for inﬂation and the age of the
family reference person, was a relative poverty
index with its values < 1.00, indicating that
the family is considered poor relative to the
ofﬁcial poverty threshold (National Center for
Health Statistics 1995).
The degree of urbanization was based on
the U.S. Department of Agriculture Rural–
Urban codes and classiﬁed into two categories
(urban, rural) (Butler and Beale 1994). All
these factors are likely to determine where the
participants live (and thus the estimated PM10
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dict CVD. Smoking status (never, past, current
smoker) and frequency of alcohol consumption
were considered potential confounders. We also
extracted the following data to be included in
the sensitivity analyses: potential sources of
indoor air pollutants (environmental tobacco
smoke, wood stove, fireplace, gas stove) and
exercise activities (jogging/running, aerobic
exercise). Substantial exposure to airborne parti-
cles from indoor sources may correlate with
outdoor PM exposure, thus raising the concern
of confounding. Physical activities may deter-
mine the level of exposure to ambient air pollu-
tants, and the frequency of engaging in
jogging/running and aerobic exercise was asso-
ciated with inﬂammatory markers in NHANES
III participants (King et al. 2003).
Statistical analyses. Because NHANES
participants were sampled from communities,
WBC counts of individuals from the same
cluster were expected to correlate with each
other, likely because of geographic difference in
population composition, nutritional status,
and characteristics of residential neighborhoods
(e.g., built environment, meteorologic factors).
To account for this spatial autocorrelation, we
used mixed-effects models to estimate the asso-
ciation between WBC count and estimated
community-level exposure to PM10. The con-
structed mixed-effects models allow for regres-
sion analyses with a covariance structure
assuming a common correlation within these
sampling units and a random-effects term for
each community, providing proper standard
error estimates for the regression parameters
under these circumstances. We compared the
average WBC count across communities
deﬁned by the quartile distribution of PM10 1
year before the examination. The potential
modiﬁcation of PM effect by the presence of
MS was examined by comparing the spatial
difference in WBC count, as putatively related
to 1-year PM10 levels, across subgroups deﬁned
by the number of MS component abnormali-
ties. The ﬁnal mixed-effects models included
the number of MS component abnormalities
and also adjusted for age, sex, race, socioeco-
nomic factors (education, income, employ-
ment status, poverty–income ratio, family size),
smoking status, alcohol consumption, and
urban–rural difference. All these analyses were
restricted to NHANES III phase 1 participants
who had available geocoded information with
estimable PM10 data and fulfilled the afore-
mentioned eligibility criteria. As a result, we
noted that none of the assigned sampling
weights in the publicly accessible data ﬁles are
appropriate to conduct weighted regression
analyses. We also carried out additional analy-
ses to examine the possible confounding by
concurrent exposure to indoor air pollutants or
by exercise activities and to evaluate whether
our findings on effect modification by MS
were sensitive to the exclusion of subjects with
known hypertension and diabetes mellitus
before the MEC examination. All mixed-
effects models were constructed using STATA
8.1 software (StataCorp., College Station, TX)
with the xtreg command.
Results
Characteristics of study population and ambi-
ent PM10 exposure. Among those 44 communi-
ties selected in phase 1 of NHANES III, 33 had
PM10 monitoring stations operating within the
residing counties or adjoining counties in
1988–1991. Table 1 shows the demographic
characteristics of U.S. adults participating in
phase 1 of NHANES III. Compared with par-
ticipants with estimable PM10 (n =5,369), sub-
jects with missing exposure data were slightly
Chen and Schwartz
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Table 2. Population correlates of quartile distribution of estimated 1-year average PM10 exposure.
Characteristic 1st 2nd 3rd 4th
Age (years) 835 (50.9 ± 18.4) 687 (49.9 ± 17.6) 726 (46.9 ± 17.8) 730 (46.0 ± 16.8)
Ethnicity
Non-Hispanic white 434 (52) 297 (43) 293 (40) 152 (21)
Non-Hispanic black 226 (27) 133 (19) 237 (33) 82 (11)
Hispanics and others 175 (21) 257 (37) 196 (27) 496 (68)
Sex
Male 422 (51) 368 (54) 368 (51) 369 (5)
Female 413 (49) 319 (46) 358 (49) 361 (49)
Years of education 832 (11.7 ± 3.8) 685 (11.4 ± 4.2) 721 (11.2 ± 3.7) 724 (10.1 ± 4.7)
Annual family income > $50,000
No 561 (75) 503 (80) 554 (85) 557 (88)
Yes 187 (25) 129 (20) 101 (15) 77 (12)
Poverty–income ratio 748 (2.87 ± 1.76) 632 (2.82 ± 1.76) 655 (2.35 ± 1.52) 634 (2.42 ± 1.55)
Urbanization
Urban 444 (53) 486 (71) 560 (77) 564 (77)
Rural 391 (47) 201 (29) 166 (23) 166 (23)
Smoking
Never 399 (48) 320 (47) 313 (43) 385 (53)
Past 247 (30) 206 (30) 195 (27) 181 (25)
Active 189 (23) 161 (23) 218 (30) 164 (23)
Metabolic syndrome 
No 61 (73.9) 520 (75.7) 567 (78.1) 525 (71.9)
Yes 218 (26.1) 167 (24.3) 159 (21.9) 205 (28.1)
Values are no. (%) or no. (mean ± SD). Total number of subjects summed across each subcategory varies slightly because
of missing values.
Table 1. Demographic characteristics of current study participants and source population in the first
period of NHANES III, 1988–1991.
Adult subjects with Adults subjects with
Characteristic missing PM10 data estimable PM10 data Current study population
Age (years) 3,037 (49.6 ± 20.4) 5,369 (48.9 ± 19.3) 2,978 (48.5 ± 17.8)
Ethnicity
Non-Hispanic white 1,728 (57) 1,995 (37) 1,176 (39)
Non-Hispanic black 749 (25) 1,415 (26) 678 (23)
Mexican American 530 (18) 1,726 (32) 1,008 (39)
Others 30 (1) 233 (4) 116 (4)
Sex
Male 1,401 (49) 2,716 (51) 1,527 (51)
Female 1,461 (51) 2,653 (49) 1,451 (49)
Years of education 3,014 (10.7 ± 3.7) 5,328 (11.0 ± 4.1) 2,962 (11.1 ± 5.1)
Annual family income
< $20,000 1,403 (52) 2,184 (46) 1,085 (41)
$20,000–35,000 711 (26) 1,160 (24) 660 (25)
$35,000–50,000 330 (12) 664 (14) 430 (16)
> $50,000 266 (10) 748 (16) 494 (18)
Poverty–income ratio 2,561 (2.07 ± 1.48) 4,757 (2.46 ± 1.64) 2,669 (2.62 ± 1.67)
Urbanization
Urban 539 (18) 3,622 (67) 2,054 (69)
Rural 2,498 (82) 1,747 (33) 924 (31)
Smoking
Never 1,348 (44) 2,542 (48) 1,417 (48)
Past 775 (26) 1,423 (27) 829 (28)
Active 914 (30) 1,404 (26) 732 (25)
MS 
No 1,718 (71.4) 3,435 (74.8) 2,229 (74.9)
Yes 689 (28.6) 1,158 (25.2) 749 (25.1)
WBC count (× 106/L) 2,651 (7,309 ± 2,370) 4,975 (7,142 ± 2,263) 2,978 (6,909 ± 1,617)
Values are no. (%) or no. (mean ± SD). The total number of subjects summed across each subcategory varies slightly
because of missing values.older (p = 0.09), more likely to be minorities
(p < 0.0001), and had higher MS prevalence
(p = 0.002) and WBC count (p < 0.0001).
These comparisons denoted that the missing
data structure of PM10 exposure levels was
dependent on demographic and geographic dif-
ferences, making extant NHANES III sampling
weights not applicable to our analyses. There
were 2,978 adults (48.5 ± 17.8 years of age)
who had estimable 1-year PM10 and met the
eligibility criteria (no prior heart attack or
stroke, normal WBC count, living in current
residences > 1 year, complete MS proﬁles). As a
result of these restrictions, there were more
Hispanics but fewer non-Hispanic blacks
(p < 0.0001) in our study, and they had lower
WBC counts than those excluded subjects with
estimable PM10, although age, sex distribution,
and MS prevalence were comparable. Our
study population had fewer active smokers (p =
0.004), and they were more likely to be of high
socioeconomic status (p < 0.0001 for compari-
son of family income and poverty–income
ratio) and live in urban areas (p = 0.008).
However, there was no difference (p = 0.47) in
the exposure distribution between our study
population (1-year average PM10 ± SD:
36.8 ± 13.0 µg/m3) and those excluded from
the analyses (37.5 ± 13.1 µg/m3). We also
noted that 94% of the observed variability in
1-year average PM10 could be attributable to
between-community difference.
The population correlates across communi-
ties defined by the quartile distribution of
1-year PM10 are presented in Table 2. As
expected, older participants (p < 0.0001) and
those with higher socioeconomic positions
(p < 0.0001 for both education and income
comparisons) were more likely to reside in the
clean air communities, and only 53% of such
communities were located in urban areas (vs.
71–77% for the other polluted communities;
p < 0.0001). In the most polluted communities,
there were more minority populations
(Hispanics and others: 68% vs. 21%, compared
with the clean air communities), and the major-
ity (78%) were located in urban areas.
Interestingly, the most polluted communities
also had the highest MS prevalence compared
with the others (28% vs. 21–26%; p = 0.045) 
Associations between PM10 and WBC
count. In Table 3, we tabulated the statistically
signiﬁcant difference in geographic distribution
of average WBC count across communities
deﬁned by the quartile distribution of PM10 1
year before the examination (p = 0.01). Subjects
from the clean air communities (in the 1st quar-
tile of 1-year PM10) had the lowest WBC count
(6,745 ± 81 × 106/L), whereas the highest aver-
age WBC counts (7,094 ± 60 × 106/L) were
found in the most polluted communities (in the
4th quartile of 1-year PM10). We present in
Table 4 the results of multivariable-adjusted
mixed-effects models to estimate the effect of
PM10 exposure on WBC count, by comparing
subjects from the clean air communities (all
with estimated 1-year PM10 < 1st quartile
cutoff: 27.8 µg/m3) with all others residing in
more polluted areas. In the crude analysis, this
spatial difference in average WBC count associ-
ated with PM10 exposure was 239 × 106/L
[95% conﬁdence interval (CI), 58–420]. This
effect estimate was diminished to 145 × 106/L
(95% CI, 10–281) but remained statistically
signiﬁcant (p = 0.035) after adjustment for age,
sex, race, socioeconomic factors (education,
household income, employment status,
poverty–income ratio, family size), smoking sta-
tus, alcohol consumption, urban–rural differ-
ence, and the number of MS component
abnormalities (model 1 of Table 4). As
expected, the presence of MS is consistently
associated with signiﬁcant systemic inﬂamma-
tion (p < 0.0001), with WBC count increased
by 204 × 106/L (95% CI, 156–254) for each
MS component abnormality.
Effect modification by the degree of MS.
Figure 1 depicts the MS-dependent spatial
difference in average WBC count associated
with PM10 exposure. Among those without
MS, there was no appreciable spatial differ-
ence in average WBC count comparing sub-
jects from the clean air communities with
others residing in more polluted areas. The
corresponding mixed-effects model revealed a
graded association between PM10 and WBC
count as the number of MS components
increased, with 91 × 106/L difference in
WBC estimated for those with no MS versus
214, 338, and 461 × 106/L for those with
three, four, and ﬁve metabolic abnormalities,
respectively (trend-test p = 0.15).
Sensitivity analyses. Results of our sensitiv-
ity analyses (model 2 and model 3 of Table 3)
conformed to the previous notion of very little
confounding of PM effect on cardiovascular
risks by indoor sources of air pollution or
other lifestyle behaviors in the NHANES III
Long-term PM10, metabolic syndrome, and WBCs
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Table 3. Spatial difference in average WBC count across communities with different levels of estimated
1-year average PM10 exposure, by quartile.
1st 2nd  3rd 4th 
Average WBC count ± SEa (× 106/L) 6,760 ± 79 6,942 ± 99 6,895 ± 84 7,109 ± 61
Median (range) of 1-year PM10 (µg/m3) 23.1 (14.6–27.8) 31.2 (27.9–34.3) 38.8 (34.3–43.3) 53.7 (43.3–78.5)
aAverage WBC count and SE estimated by mixed-effects modeling adjusted for within-cluster correlation.
Table 4. Mixed-effects modeling of spatial difference in WBC count associated with 1-year average PM10
exposure.
Crude Model 1a Model 2b Model 3c
β (× 106/L)d 239 145 141 138
95% CId 58–420 10–281 6–277 2–273
p-Value 0.01 0.035 0.041 0.046
aAdjusted for within-cluster correlation, age, sex, race, socioeconomic factors (education, income, employment status,
poverty–income ratio, family size), smoking status, alcohol consumption, urban/rural designation, and number of MS
abnormalities. bModel 1 plus additional adjustment for sources of indoor air pollutants (environmental tobacco smoke,
wood stove, ﬁreplace, gas stove). cModel 1 plus additional adjustment for indoor air pollutants (environmental tobacco
smoke, wood stove, ﬁreplace, gas stove) and exercise activities (jogging/running, aerobic exercise). dRegression coefﬁ-
cient and 95% CI representing the difference in average WBC count comparing participants residing in clean air commu-
nities (1st quartile of 1-year PM10) with those living in other, more polluted areas.
Figure 1. Differential inﬂammatory responses to long-term PM exposure according to the degree of MS. A
graded increment of spatial difference in average WBC count compares participants residing in clean air
communities (1st quartile of 1-year PM10) with those living in the other, more polluted areas associated
with increasing number of MS component abnormalities (p = 0.15 for the trend-test; p = 0.044 after exclud-
ing subjects with established hypertension and/or diabetes mellitus). 
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Clean Polluted Clean Polluted Clean Polluted Clean Polluted Clean Polluted Clean Pollutedparticipants (Schwartz 2001). After we added
potential sources of indoor air pollutants and
subsequently exercise activities to the adjusted
mixed-effects models, we found only minor
changes to the effect estimate (with spatial dif-
ference in WBC count: 141 × 106/L, p = 0.041
and 138 × 106/L, p = 0.046, respectively).
Results of our sensitivity analysis also support
the finding on MS-dependent spatial differ-
ence in average WBC count associated with
PM10 exposure. After excluding those subjects
(n = 700) with existing physician-diagnosed
hypertension or diabetic mellitus and updating
the corresponding mixed-effects model, we still
observed a graded association between PM10
and WBC count, showing an even greater dif-
ference in WBC count as the number of MS
abnormalities increased (with 87 × 106/L dif-
ference in WBC count estimated for those
with no MS, versus 353, 617, and 886 × 106/L
for those with three, four, and ﬁve metabolic
abnormalities), and the test of effect modiﬁca-
tion by MS status became statistically signiﬁ-
cant (trend-test p = 0.044).
Discussion
Our study results demonstrated that hemato-
logic inﬂammatory markers of increased CVD
risks, as reflected by increased WBC count,
were associated with long-term (1 year) PM10
exposure, and such an association could not be
attributable completely to the between-
individual differences in demographics, socio-
economic factors, lifestyles, urban–rural
locations, sources of indoor air pollutants, and
conventional CVD risk factors used to deﬁne
MS. This study provided the ﬁrst epidemio-
logic data linking inﬂammatory biomarkers to
long-term PM exposure and supports the
hypothesized involvement of inﬂammation in
PM-mediated chronic cardiovascular effects.
Previously, large population-based cohort
studies, such as the Framingham Heart Study
(Kannel et al. 1992) and the Atherosclerosis
Risk in Communities Study (Lee et al. 2001),
reported an increase in long-term CVD risks
associated with high WBC count. More recent
data from the Women’s Health Initiative
Observational Study further demonstrated
WBC count as a stable and well-standardized
marker of vascular inﬂammation independent
of C-reactive protein in predicting long-term
CVD events (Margolis et al. 2005). Short-
term elevations of ambient PM10 levels were
also associated with increases in WBC count
(Liao et al. 2005; Schwartz 2001). Taken
together, these scientific data highlight the
importance of inﬂammation in the mechanis-
tic pathways underlying both acute and
chronic adverse health effects of PM exposure.
The observed differential inflammatory
responses across individuals with different
degrees of metabolic abnormalities support the
concept that the presence of MS may impart
greater susceptibility to PM-associated long-
term cardiovascular effects. This new evidence
is in line with previous epidemiologic observa-
tions that individuals with obesity (Chen et al.
2007; Dubowsky et al. 2006; Schwartz et al.
2005), hypertension (Holguin et al. 2003; Liao
et al. 2005; Park et al. 2005), and diabetes mel-
litus (O’Neill et al. 2005; Park et al. 2005) are
more susceptible to PM-associated acute cardiac
effects. It also conforms to recent data from the
Women’s Health Initiative Observational
Study, where investigators found a graded
increase in the relative risk for incident CVD
associated with long-term ambient PM2.5 expo-
sures among postmenopausal women with
increasing level of obesity (Miller et al. 2007).
The positive association we found between
long-term PM exposure with increased inﬂam-
matory responses as well as the empirical evi-
dence on the enhanced susceptibility among
subjects with MS is also consistent with a
small number of toxicologic studies that just
began to elucidate the mechanisms of chronic
PM effects on CVD, using chronic exposures
in animals with underlying metabolic abnor-
malities. In a susceptible animal model of
Watanabe heritable hyperlipidemic rabbits
(Suwa et al. 2002), instillation with PM10(col-
lected from outdoor air in Ottawa, Ontario,
Canada) for 4 weeks was found to accelerate
the progression of coronary atherosclerosis.
PM10-instillation also increased plaque cell
turnover and extracellular lipid pools in both
coronary and aortic atherosclerotic lesions. In
one study of concentrated air particles (Sun
et al. 2005), after exposing apolipoprotein E-
null mice to PM2.5 for 6 months (with equiva-
lent concentration of 15.2 µg/m3, collected in
Tuxedo, NY), researchers found that trans-
verse sections of abdominal aorta increased
1.58-fold in percentage plaque area among
mice maintained on high-fat, but not regular,
chow. Further morphometric and immuno-
histochemical analyses indicated that vascular
inflammation was elevated in atherosclerotic
plaques of PM-exposed mice.
Our study ﬁndings raise several mechanis-
tic questions that remain to be answered. For
instance, what are the toxicokinetic and/or
toxicodynamic features underscoring the
PM-induced long-term inﬂammation among
individuals with MS that can explain the
observed MS-dependent inflammatory
responses? In an inhalation study of healthy
children 6–13 years of age, body mass index
was associated with a graded increase in the
estimated total lung dose of deposited fine
particle (i.e., deposited particles/time)
(Bennett and Zeman 2004), although whether
obesity also increases particle deposition in
adults with MS has not been demonstrated.
Does any existing systemic inﬂammation, such
as that reﬂected by increased WBC count in
persons with MS, provide some mechanistic
substrates predisposing affected individuals to
an increased inflammatory response to air-
borne particles? This speculation, however, is
not supported by empirical results of our sensi-
tivity analyses, where we found an even greater
difference in WBC count associated with 1-
year PM10 after excluding those who had
physician-diagnosed hypertension or diabetes
mellitus, two clinical conditions with presum-
ably high degrees of systemic inflammation.
Interestingly, recent analyses of the Women’s
Health Initiative Observational Study cohort
data showed that women with prior hyperten-
sion or diabetes did not have heightened risks
for CVD-associated long-term PM2.5 exposure
when compared with women with no hyper-
tension or diabetes (Miller et al. 2007). These
data may suggest a complex pattern of interac-
tion in human studies when the indicators of
individual susceptibility involve clinical comor-
bidities. For instance, the concurrent use of
medications such as anti-inﬂammatory agents
may impart different levels of susceptibility not
captured in our analyses. It is also arguable that
residential mobility may depend on clinical
comorbidities, making 1-year average not a
good surrogate of long-term exposure among
those with preexisting hypertension or dia-
betes. Biologically speaking, these findings
may imply that future research should look
into some preclinical pathophysiologic
processes that likely parallel either the toxico-
kinetic or toxicodynamic pathways under-
lying the MS-dependent long-term effect of
PM exposure.
We recognize that our secondary data
analysis has the following limitations that call
for future studies to fully address them: First,
because of its cross-sectional design, the
observed association between increased WBC
count and estimated 1-year PM10 exposure
before the laboratory examination cannot be
interpreted as deﬁnitely causal without any cau-
tion. Although we could not provide any good
reasons why individuals with preexisting nor-
mal but relatively low WBC counts might have
preferred or chosen to live in clear air commu-
nities, it is statistically arguable that residents
from clean air communities might happen to
have WBC counts lower than others at base-
line. Second, although we have adjusted for a
large set of individual-level confounders and
some other residential characteristics, we could
not rule out the possibility of unmeasured con-
founding. Because WBC count is a sensitive
hematologic marker for various physical and
psychosocial stressors, future studies may need
to consider other contextual features (e.g.,
crime rate, characteristics of built environment)
of the residential environment that are associ-
ated with CVD risks and may also covary with
ambient air pollution levels. Third, using his-
torical environmental monitoring data as the
only information source for an individual-level
Chen and Schwartz
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exposure assignment, we were unable to relate
the spatial difference in WBC count to other
related features of ambient PM exposure
beyond the varying PM10 levels across the com-
munities. For instance, we did not know
whether there were similar associations with
long-term exposure to ambient PM of different
size characterization (e.g., PM2.5, coarse PM).
Although the effects of other copollutants were
not the focus of the present study, we did con-
duct some additional analyses and did not ﬁnd
associations between WBC count and esti-
mated levels of other ambient air pollutants,
including O3, NO2, and SO2 (data not shown).
Fourth, because no nationwide PM speciation
data were available for 1988–1991, we failed to
identify speciﬁc constituents or investigate any
important PM10 sources responsible for the
putative long-term inﬂammatory responses to
ambient air particles. Given that so much of the
observed exposure variability (94%) is domi-
nated by PM10 gradients across communities,
our study ﬁndings may imply some inﬂamma-
tory responses induced by exposure to long-
term PM of regional sources. Although earlier
cohort analyses on cardiopulmonary mortality
spoke to the importance of regional-scale PM
sources, more recent studies were able to show
the effect on CVD across PM gradients within
cities (Jerrett et al. 2005; Miller et al. 2007),
suggesting the signiﬁcance of local PM sources
as well. Whether long-term exposure to PM of
local-scale sources can induce inflammatory
responses needs further investigation. Fifth,
because most PM10 data were monitored only
every 6 days, which rarely coincided with the
NHANES III examination day, there were only
708 subjects within our deﬁned study popula-
tion (n = 2,978) for whom both daily and
1-year PM10 data were available concurrently
with the WBC measurement, making it
impractical to jointly model the presumably
independent effects of daily and annual average
PM10 exposures. Nonetheless, we noted in our
restricted sample that the correlation coefﬁcient
between daily and 1-year PM10 estimates was
0.09. This empirically modest correlation sug-
gests that short-term PM exposure contributes
only a small portion, if any, of the overall
inﬂammatory response to long-term repeated
PM exposure. Finally, increased WBC count is
a nonspeciﬁc hematologic marker of inﬂamma-
tion. Future epidemiologic data on more spe-
cific molecular markers (e.g., expression of
C-reactive protein or other biomarkers of
vascular inﬂammation) are needed to conﬁrm
previous animal and in vitro studies.
Conclusions
The consistent PM10-related spatial difference
in WBC count in our study denotes the pres-
ence of inflammatory responses involved in
either the development or progression of CVD
associated with long-term PM exposure. The
observed increasing inflammatory response
across subpopulations with more MS compo-
nent abnormalities supports the concept of
MS-dependent susceptibility to PM-associated
long-term cardiovascular effects.
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